RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells.
Mortier C, Gracey E, Coudenys J, Manuello T, Decruy T, Maelegheer M, Stappers F, Gilis E, Gaublomme D, Van Hoorebeke L, Van Welden S, Ambler C, Hegen M, Symanowicz P, Steyn S, Berstein G, Elewaut D, Venken K.
Mortier C, et al. Among authors: van welden s.
Rheumatology (Oxford). 2023 Sep 1;62(9):3169-3178. doi: 10.1093/rheumatology/kead022.
Rheumatology (Oxford). 2023.
PMID: 36661300